查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1682037

2025年細胞裂解和分餾全球市場報告

Cell Lysis And Fractionation Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年細胞裂解和分餾市場規模將強勁成長。到 2029 年，這一數字將成長至 48.9 億美元，複合年成長率為 7.0%。預測期內的成長可歸因於對個人化醫療的日益關注、政府對研究的資助增加、對有效方法的高需求、基因組學和蛋白​​質組學領域的技術進步以及慢性病和感染疾病病率的上升。預測期內的關鍵趨勢包括個人化醫療方法的採用持續成長、裂解和分餾過程中自動化和機器人技術的提高、臨床診斷和藥物開發中的應用不斷擴大、用於細胞分析的微流體和實驗室晶片技術的進步，以及對照護現場和分散式檢查解決方案的日益重視。

個人化醫療日益受到關注預計將在未來幾年推動細胞裂解和分餾市場的成長。個人化醫療是一種新興的醫療實踐，利用個人的基因特徵來診斷和治療疾病。它涉及根據每個患者的獨特特徵量身定做醫療決策和治療，特別關注他們的基因組成。細胞裂解和分餾在精準醫療中發揮關鍵作用，因為它能夠從患者樣本中分離和分析特定的亞細胞成分，例如蛋白質、細胞器和核酸。這使得科學家和醫療專業人員能夠研究疾病背後的分子過程，並根據每位患者獨特的分子特徵制定客製化治療方案。例如，根據致力於促進個人化醫療理解和傳播的美國組織個人化醫療聯盟（PMC）預測，到2022年10月，市場上將有超過75,000種基因檢測產品和超過300種個人化藥物，用於治療多種癌症、罕見遺傳疾病以及多種慢性病和感染疾病。因此，對個人化醫療的日益關注正在推動細胞裂解和分餾市場的成長。

細胞裂解和分餾市場的主要企業正專注於引入先進的解決方案，例如 CGT（細胞和基因療法）病毒載體裂解試劑套件，以在市場上獲得競爭優勢。這些裂解套件提供了一種簡化的 AAV（腺結合病毒）裂解方法，標準化了生物製程工作流程，同時改善了 SOP（標準操作程序）、品管和安全性。例如，2023年7月，德國樣本和檢測技術供應商QIAGEN推出了新的CGT病毒載體裂解套件。該套件可以從細胞裂解物開始，以準確、統一的程序對幾种血清型的病毒滴度進行量化。新型 CGT 病毒載體裂解試劑套件是對 QIAGEN 為生物製藥行業快速擴展的數位 PCR 產品組合的補充，該產品組合已包括三種 QIAcuity 殘留 DNA 定量試劑盒（用於檢查宿主細胞 DNA 的殘留）和 10 種 QIAcuity 細胞和基因治療 (CGT) dPCR 檢測試劑盒（用於腺結合病毒滴度）。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球細胞裂解和分餾 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球細胞裂解與分餾市場：成長率分析
  • 全球細胞裂解與分餾市場表現：規模與成長，2019-2024
  • 全球細胞裂解與分餾市場預測：規模與成長，2024-2029 年，2034 年預測
  • 全球細胞裂解和分餾總目標市場（TAM）

第6章市場區隔

  • 全球細胞裂解和分餾市場：按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 哺乳動物細胞
  • 微生物細胞
  • 全球細胞裂解和分餾市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 核酸精製與分離
  • 蛋白質精製與分離
  • 全球細胞裂解和分餾市場：按最終用戶、業績和預測，2019-2024 年、2024-2029 年、2034 年
  • 研究室和實驗室
  • 生物製藥
  • 生技公司
  • 全球細胞裂解和分餾市場、哺乳動物細胞細分、按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 貼壁哺乳動物細胞
  • 懸浮哺乳動物細胞
  • 初代細胞
  • 細胞株
  • 全球細胞裂解和分餾市場微生物細胞細分，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 細菌細胞
  • 酵母菌細胞
  • 真菌細胞
  • 藻類細胞

第7章 區域和國家分析

  • 全球細胞裂解及分餾市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球細胞裂解和分餾市場：按國家/地區、績效和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 細胞裂解與分餾市場：競爭格局
  • 細胞裂解和分餾市場：公司簡介
    • Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Lonza Group AG
  • Illumina Inc.
  • Beckman Coulter Inc.
  • PerkinElmer Inc.
  • IDEX Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Eppendorf AG
  • Miltenyi Biotec BV & Co. KG
  • Promega Corporation
  • Takara Bio Inc.
  • Abcam plc
  • Cell Signaling Technology Inc.
  • BioVision Inc.
  • Diagenode LLC

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年細胞裂解和分餾市場：提供新機會的國家
  • 2029年細胞裂解與分餾市場：細分市場帶來新機會
  • 2029年細胞裂解與分餾市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r27643

Cell lysis is the process of breaking open a cell, which allows the release of its contents, while cell fractionation is a multi-step laboratory procedure used to divide a cell's organelles into various layers or fractions or sections.

The main types of cell lysis and fractionation are mammalian cells and microbial cells. Mammalian cells are eukaryotic cells that are derived from mammals and are used in cell culture and biomanufacturing of therapeutic proteins and viral vaccines. These are used for various applications, such as nucleic acid purification and isolation and protein purification and isolation, and are used by several end users, including research laboratories and institutes, biopharmaceutical, and biotechnology companies.

The main types of cell lysis and fractionation are mammalian cells and microbial cells. Mammalian cells are eukaryotic cells that are derived from mammals and are used in cell culture and biomanufacturing of therapeutic proteins and viral vaccines. These are used for various applications, such as nucleic acid purification and isolation and protein purification and isolation, and are used by several end users, including research laboratories and institutes, biopharmaceutical, and biotechnology companies.

The cell lysis and fractionation market size has grown strongly in recent years. It will grow from $3.42 billion in 2024 to $3.72 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to increasing investments in life science research, growing focus on personalized medicine, high prevalence of diseases, technological advancements in cell lysis and fractionation methods, rising demand for biopharmaceuticals and biotechnology products.

The cell lysis and fractionation market size is expected to see strong growth in the next few years. It will grow to $4.89 billion in 2029 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to growing focus on personalized medicine, increasing government funding for research, high demand for effective cell lysis and fractionation methods, technological advancements in the field of genomics and proteomics, rising prevalence of chronic and infectious diseases. Major trends in the forecast period include continued growth in the adoption of personalized medicine approaches, increasing integration of automation and robotics in lysis and fractionation processes, expansion of applications in clinical diagnostics and drug development, advancements in microfluidics and lab-on-a-chip technologies for cell analysis, growing emphasis on point-of-care and decentralized testing solutions.

A growing focus on personalized medicine is expected to propel the growth of the cell lysis and fractionation markets going forward. Personalized medicine is an emerging practice of medicine that uses an individual's genetic profile for the diagnosis and treatment of disease. It involves tailoring medical decisions and treatments to the individual characteristics of each patient, particularly focusing on their genetic makeup. Cell lysis and fractionation play a crucial part in precision medicine by making it possible to separate and analyze particular subcellular elements from patient samples, including proteins, organelles, and nucleic acids. This makes it possible for scientists and medical professionals to investigate the molecular processes that underlie illness and create customized treatments depending on the unique molecular traits of each patient. For instance, in October 2022, according to the Personalized Medicine Coalition (PMC), a US-based organization that promotes understanding and adoption of personalized medicine, more than 75,000 genetic testing products and 300 personalized medicines will be on the market for people with multiple types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. Therefore, the growing focus on personalized medicine is driving the growth of the cell lysis and fractionation markets.

Major companies operating in the cell lysis and fractionation market are focused on introducing advanced solutions, such as CGT (cell and gene therapy) viral vector lysis kits, to gain a competitive edge in the market. These lysis kits offer a simplified AAV (Adeno-associated virus) lysis methodology that will improve SOPs (Standard Operating Procedures), quality control, and safety while standardizing bioprocessing workflows. For instance, in July 2023, QIAGEN, a Germany-based provider of sample and assay technologies, launched the new CGT Viral Vector Lysis Kit, which makes it possible to quantify virus titers for several serotypes with an exact and uniform procedure starting with cell lysates. The new CGT viral vector lysis kit complements QIAGEN's rapidly expanding digital PCR portfolio for the biopharma industry, which already includes three QIAcuity Residual DNA Quantification Kits to check for host cell DNA carryover and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays for use in adeno-associated virus (AAV) titer quantification.

In December 2022, MilliporeSigma, a US-based pharmaceutical company, acquired Erbi Biosystems Inc. for an undisclosed amount. With this acquisition, MilliporeSigma aims to strengthen its portfolio and expertise in the field of bioreactors and cell culture technologies. Erbi Biosystems is the developer of the 2 ml micro-bioreactor platform technology known as Breez, which is a micro-scale, fully automated, functionally closed system. Erbi Biosystems Inc. is a US-based biotechnology company that offers microfluidic solutions to enable efficient and controlled cell lysis and fractionation.

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

North America was the largest region in the cell lysis and fractionation market in 2024. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell lysis and fractionation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell lysis and fractionation market consists of revenues earned by entities by providing cellular contents extraction, cytoplasmic separation, and cell disruption. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell lysis and fractionation market also includes sales of cell lysis instruments, cell lysis reagents, and consumables. Values in this market are 'factory gate' values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Lysis And Fractionation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell lysis and fractionation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell lysis and fractionation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell lysis and fractionation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Mammalian Cells; Microbial Cells
  • 2) By Application: Nucleic Acid Purification And Isolation; Protein Purification And Isolation
  • 3) By End-User: Research Laboratories And Institutes; Biopharmaceutical; Biotechnology Companies
  • Subsegments:
  • 1) By Mammalian Cells: Adherent Mammalian Cells; Suspension Mammalian Cells; Primary Cells; Cell Lines
  • 2) By Microbial Cells: Bacterial Cells; Yeast Cells; Fungal Cells; Algal Cells
  • Companies Mentioned: Hoffmann-La Roche Ltd; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Lysis And Fractionation Market Characteristics

3. Cell Lysis And Fractionation Market Trends And Strategies

4. Cell Lysis And Fractionation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cell Lysis And Fractionation Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cell Lysis And Fractionation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cell Lysis And Fractionation Market Growth Rate Analysis
  • 5.4. Global Cell Lysis And Fractionation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cell Lysis And Fractionation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cell Lysis And Fractionation Total Addressable Market (TAM)

6. Cell Lysis And Fractionation Market Segmentation

  • 6.1. Global Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mammalian Cells
  • Microbial Cells
  • 6.2. Global Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nucleic Acid Purification And Isolation
  • Protein Purification And Isolation
  • 6.3. Global Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Laboratories And Institutes
  • Biopharmaceutical
  • Biotechnology Companies
  • 6.4. Global Cell Lysis And Fractionation Market, Sub-Segmentation Of Mammalian Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adherent Mammalian Cells
  • Suspension Mammalian Cells
  • Primary Cells
  • Cell Lines
  • 6.5. Global Cell Lysis And Fractionation Market, Sub-Segmentation Of Microbial Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacterial Cells
  • Yeast Cells
  • Fungal Cells
  • Algal Cells

7. Cell Lysis And Fractionation Market Regional And Country Analysis

  • 7.1. Global Cell Lysis And Fractionation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cell Lysis And Fractionation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell Lysis And Fractionation Market

  • 8.1. Asia-Pacific Cell Lysis And Fractionation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell Lysis And Fractionation Market

  • 9.1. China Cell Lysis And Fractionation Market Overview
  • 9.2. China Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell Lysis And Fractionation Market

  • 10.1. India Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell Lysis And Fractionation Market

  • 11.1. Japan Cell Lysis And Fractionation Market Overview
  • 11.2. Japan Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell Lysis And Fractionation Market

  • 12.1. Australia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell Lysis And Fractionation Market

  • 13.1. Indonesia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell Lysis And Fractionation Market

  • 14.1. South Korea Cell Lysis And Fractionation Market Overview
  • 14.2. South Korea Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell Lysis And Fractionation Market

  • 15.1. Western Europe Cell Lysis And Fractionation Market Overview
  • 15.2. Western Europe Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell Lysis And Fractionation Market

  • 16.1. UK Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell Lysis And Fractionation Market

  • 17.1. Germany Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell Lysis And Fractionation Market

  • 18.1. France Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell Lysis And Fractionation Market

  • 19.1. Italy Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell Lysis And Fractionation Market

  • 20.1. Spain Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell Lysis And Fractionation Market

  • 21.1. Eastern Europe Cell Lysis And Fractionation Market Overview
  • 21.2. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell Lysis And Fractionation Market

  • 22.1. Russia Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell Lysis And Fractionation Market

  • 23.1. North America Cell Lysis And Fractionation Market Overview
  • 23.2. North America Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell Lysis And Fractionation Market

  • 24.1. USA Cell Lysis And Fractionation Market Overview
  • 24.2. USA Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell Lysis And Fractionation Market

  • 25.1. Canada Cell Lysis And Fractionation Market Overview
  • 25.2. Canada Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell Lysis And Fractionation Market

  • 26.1. South America Cell Lysis And Fractionation Market Overview
  • 26.2. South America Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell Lysis And Fractionation Market

  • 27.1. Brazil Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell Lysis And Fractionation Market

  • 28.1. Middle East Cell Lysis And Fractionation Market Overview
  • 28.2. Middle East Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell Lysis And Fractionation Market

  • 29.1. Africa Cell Lysis And Fractionation Market Overview
  • 29.2. Africa Cell Lysis And Fractionation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cell Lysis And Fractionation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cell Lysis And Fractionation Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell Lysis And Fractionation Market Competitive Landscape And Company Profiles

  • 30.1. Cell Lysis And Fractionation Market Competitive Landscape
  • 30.2. Cell Lysis And Fractionation Market Company Profiles
    • 30.2.1. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Cell Lysis And Fractionation Market Other Major And Innovative Companies

  • 31.1. Lonza Group AG
  • 31.2. Illumina Inc.
  • 31.3. Beckman Coulter Inc.
  • 31.4. PerkinElmer Inc.
  • 31.5. IDEX Corporation
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. QIAGEN NV
  • 31.8. Eppendorf AG
  • 31.9. Miltenyi Biotec B.V. & Co. KG
  • 31.10. Promega Corporation
  • 31.11. Takara Bio Inc.
  • 31.12. Abcam plc
  • 31.13. Cell Signaling Technology Inc.
  • 31.14. BioVision Inc.
  • 31.15. Diagenode LLC

32. Global Cell Lysis And Fractionation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Lysis And Fractionation Market

34. Recent Developments In The Cell Lysis And Fractionation Market

35. Cell Lysis And Fractionation Market High Potential Countries, Segments and Strategies

  • 35.1 Cell Lysis And Fractionation Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cell Lysis And Fractionation Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cell Lysis And Fractionation Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer